Posts Tagged ‘Update’

News Update: Shares of ImmunoGen, Inc. Up After 40% Plunge from Friday

Shares of ImmunoGen, Inc. (NASDAQ:IMGN) were up 10% earlier Monday to $5.66, reports Market Watch. Shares of the company dove 40% last Friday after the accelerated approval of the Roche Holding Ltd.-developed breast cancer treatment, T-DM1, was denied by the US Food and Drug Administration. Roche will now have to wait until mid-2012 to re-apply for approval. SmarTrend currently has ImmunoGen in a Downtrend and is monitoring these developments to alert subscribers to any change of trend. Shares of the pharmaceuticals company continue to trade up 11.05% Monday afternoon at $5.73.

Roche provides update from Avastin FDA advisory committee meeting

GTx Provides Corporate Update and Reports 2010 Financial Results

GTx Provides Corporate Update and Reports 2010 Financial Results
MEMPHIS, Tenn.–(BUSINESS WIRE)–GTx provides a corporate update and announces fourth quarter and full year 2010 financial results.

Read more on Business Wire

Kathy’s 1st Video Update

Blog of young mom of two and wife who is fighting metastatic breast cancer

Peregrine Provides Update On Government-Sponsored Research Program

Peregrine Provides Update On Government-Sponsored Research Program
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment of cancer and viral infections, today provided an update on its government contract with the Transformational Medical Technologies (TMT) program of the U.S. Department of Defense’s Defense Threat Reduction Agency (DTRA).

Read more on BioresearchOnline